Clinical trial
The Effects of Chronic High-density Lipoprotein (HDL) Elevation With Extended Release Niacin on Peripheral Arterial Disease
NCT01391377 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Chronic High-density Lipoprotein (HDL) Elevation With Extended Release Niacin on Peripheral Arterial Disease
- Lead sponsor
- Bayside Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.